Daily variance of urinary excretion of AQP2 determined by sandwich ELISA method
Tóm tắt
Urinary excretion of aquaporin 2 (AQP2) is a useful marker of kidney collecting duct function. A specific and convenient method to measure AQP2 in human urine would help to treat water balance disorders. It is unknown whether urinary excretion of AQP2 shows any daily variance. A sandwich enzyme-linked immunosorbent assay (ELISA) method for AQP2 was established using two different kinds of antibodies, and its sensitivity and specificity were examined. Daily variance of urinary excretion of AQP2 and responses to acute water load were examined. The established ELISA specifically detected urine AQP2 with high sensitivity (detected as low as 0.34 pmol/mL). Urinary excretion of AQP2 did not show daily variance between 9 a.m. and 9 p.m. in healthy subjects. The developed ELISA method using two different antibodies is convenient and highly sensitive, and could be useful in clinical practice. Urinary excretion of AQP2 is relatively constant from morning to night, and spot urine sampling at any time during this time period does not affect the results.
Tài liệu tham khảo
Noda Y, Sohara E, Ohta E, Sasaki S. Aquaporins in kidney pathophysiology. Nat Rev Nephrol. 2010;6:168–78.
Brown D, Katsura T, Gustafson CE. Cellular mechanisms of aquaporin trafficking. Am J Physiol. 1998;275:F328–31.
Kanno K, Sasaki S, Hirata Y, Ishikawa S, Fushimi K, Nakanishi S, et al. Urinary excretion of aquaporin-2 in patients with diabetes insipidus. N Engl J Med. 1995;332:1540–5.
Rai T, Sekine K, Kanno K, Hata K, Miura M, Mizushima A, et al. Urinary excretion of aquaporin-2 water channel protein in human and rat. J Am Soc Nephrol. 1997;8:1357–62.
Elliot S, Goldsmith P, Knepper M, Haughey M, Olson B. Urinary excretion of aquaporin-2 in humans: a potential marker of collecting duct responsiveness to vasopressin. J Am Soc Nephrol. 1996;7:403–9.
Deen PM, van Aubel RA, van Lieburg AF, van Os CH. Urinary content of aquaporin 1 and 2 in nephrogenic diabetes insipidus. J Am Soc Nephrol. 1996;7:836–41.
Pedersen RS, Bentzen H, Bech JN, Pedersen EB. Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. Am J Physiol Renal Physiol. 2001;280:F860–7.
Martin PY, Abraham WT, Lieming X, Olson BR, Oren RM, Ohara M, et al. Selective V2-receptor vasopressin antagonism decreases urinary aquaporin-2 excretion in patients with chronic heart failure. J Am Soc Nephrol. 1999;10:2165–70.
Ivarsen P, Frøkiaer J, Aagaard NK, Hansen EF, Bendtsen F, Nielsen S, et al. Increased urinary excretion of aquaporin 2 in patients with liver cirrhosis. Gut. 2003;52:1194–9.
Ishikawa Se, Saito T, Fukagawa A, Higashiyama M, Nakamura T, Kusaka I, et al. Close association of urinary excretion of aquaporin-2 with appropriate and inappropriate arginine vasopressin-dependent antidiuresis in hyponatremia in elderly subjects. J Clin Endocrinol Metab. 2001;86:1665–71.
Ranchin B, Boury-Jamot M, Blanchard G, Dubourg L, Hadj-Aïssa A, Morin D, et al. Familial nephrogenic syndrome of inappropriate antidiuresis: dissociation between aquaporin-2 and vasopressin excretion. J Clin Endocrinol Metab. 2010;95:E37–43.
Umenishi F, Summer SN, Cadnapaphornchai M, Schrier RW. Comparison of three methods to quantify urinary aquaporin-2 protein. Kidney Int. 2002;62:2288–93.
Iacobelli S, Gouyon JB, Bonsante F, Mastrofrancesco L, Svelto M, Valenti G. Aquaporin-2 urinary excretion in preterm infants: relationship to diuresis and vasopressin. Acta Physiol. 2010;200:339–45.
Tanaka K, Ishikawa E, Ohmoto Y, Hirai Y. In vitro production of human interleukin 1 alpha and interleukin 1 beta by peripheral blood mononuclear cells examined by sensitive sandwich enzyme immunoassay. Eur J Immunol. 1987;17:1527–30.
Saito T, Ishikawa SE, Sasaki S, Nakamura T, Rokkaku K, Kawakami A, et al. Urinary excretion of aquaporin-2 in the diagnosis of central diabetes insipidus. J Clin Endocrinol Metab. 1997;82:1823–7.
Pedersen RS, Bentzen H, Bech JN, Nyvad O, Pedersen EB. Urinary aquaporin-2 in healthy humans and patients with liver cirrhosis and chronic heart failure during baseline conditions and after acute water load. Kidney Int. 2003;63:1417–25.
Lu WS, Xu DL, Yin XY, Ren H, Meng SR. Enzyme-linked immunosorbent assay for urinary aquaporin-2 water channel protein measurement. Di Yi Jun Yi Da Xue Xue Bao. 2002;22:486–9.
Nakamura T, Saito T, Kusaka I, Higashiyama M, Nagasaka S, Ishibashi S, Ishikawa, et al. Decrease in urinary excretion of aquaporin-2 associated with impaired urinary concentrating ability in diabetic nephropathy. Nephron. 2002;92:445–8.
Gross P. Treatment of hyponatremia. Intern Med. 2008;47:885–91.